Skip to main content
Clinical Trials/NCT02538835
NCT02538835UnknownNot Applicable

The Effect of Group Treatment for Depression: A Randomised Controlled Study of Metacognitive Therapy, Mindfulness and Support Groups

University of Southern Denmark1 site in 1 country165 target enrollmentStarted: August 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
165
Locations
1
Primary Endpoint
Change from baseline on Hamilton depression scale

Study Overview

Brief Summary

This study evaluates the effect of metacognitive group therapy on depression compared to mindfulness groups and supportive groups. The participants, all with a history of depression and with current symptoms of depression, will be randomized to one of the three group interventions.

Detailed Description

Metacognitive therapy (MCT) show promising results in alleviating depressive symptoms and reducing relapse of depression. However studies of MCT as a group intervention is limited and higher quality studies of the effectiveness of MCT is warranted. The present study aim to produce more conclusive evidence on the effect of MCT comparing MCT in groups with both and active control group and mindfulness based cognitive therapy (MBCT), which together with pharmacotherapy is currently one of the preferred treatment choices. Currently pharmacotherapy, cognitive therapy and MBCT seem to help 40-58% of the patients efficiently. The current studies of MCT indicate that this intervention may help a higher proportion of the patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Consent to participate
  • •History of clinical depression
  • •Current depressive symptoms
  • •Verbal and cognitive abilities to complete the questionnaires during the study
  • •Stable medication - if any medication is ordinated
  • •Speaks fluently danish

Exclusion Criteria

  • •If criteria for psychosis, bipolar disorder or personality disorder is matched
  • •known brain damage or mental retardation
  • •substance abuse
  • •women who are pregnant or breast feeding

Arms & Interventions

Metacognitive Therapy

Experimental

Intervention: Metacognitive therapy (Behavioral)

Mindfulness based cognitive therapy

Active Comparator

Intervention: Mindfulness based cognitive therapy, group (Behavioral)

Support groups

Placebo Comparator

Intervention: Support groups (Behavioral)

Outcomes

Primary Outcomes

Change from baseline on Hamilton depression scale

Time Frame: 32 weeks

Change from baseline on Hamilton depression scale

Time Frame: 8 weeks

Secondary Outcomes

  • Change from baseline on Ruminative Response Scale(32 weeks)
  • Change from baseline on Becks depression inventory(32 weeks)
  • Change from baseline on Becks Anxiety Inventory(32 weeks)
  • Change from baseline on Metacognitive questionnaire(32 weeks)
  • Change from baseline on Becks Anxiety Inventory(8 weeks)
  • Change from baseline on Becks depression inventory(8 weeks)
  • Change from baseline on Ruminative Response Scale(8 weeks)
  • Change from baseline on Metacognitive questionnaire(8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tonny Elmose Andersen, phd.

Associate Professor

University of Southern Denmark

Study Sites (1)

Loading locations...

Similar Trials